ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Samsung Biologics, National OncoVenture, and Eutilex Obtain IND Approval from FDA
January 27, 2021Samsung Biologics announced another successful Investigational New Drug (IND) clearance from the FDA for its client to begin clinical trials on a cancer immunotherapy, furthering the company's track record as a premiere CDO service provider in the ...
Pharma Sources Insight January 2025
